Compounds > palladium
Page last updated: 2024-08-22

palladium and goserelin

palladium has been researched along with goserelin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arger, P; Arjomandy, B; Broderick, GA; Epperson, RD; Kassaee, A; Malkowicz, SB; Whittington, R1
Lee, LN; Stock, RG; Stone, NN1
Burri, RJ; Cesaretti, JA; Ho, AY; Stock, RG; Stone, NN1

Other Studies

3 other study(ies) available for palladium and goserelin

ArticleYear
The effect of androgen deprivation on the early changes in prostate volume following transperineal ultrasound guided interstitial therapy for localized carcinoma of the prostate.
    International journal of radiation oncology, biology, physics, 1999, Jul-15, Volume: 44, Issue:5

    Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Brachytherapy; Combined Modality Therapy; Dose-Response Relationship, Radiation; Goserelin; Humans; Iodine Radioisotopes; Leuprolide; Male; Palladium; Prostatic Neoplasms; Radiopharmaceuticals; Ultrasonography, Interventional

1999
Role of hormonal therapy in the management of intermediate- to high-risk prostate cancer treated with permanent radioactive seed implantation.
    International journal of radiation oncology, biology, physics, 2002, Feb-01, Volume: 52, Issue:2

    Topics: Adult; Aged; Analysis of Variance; Androgen Antagonists; Brachytherapy; Combined Modality Therapy; Follow-Up Studies; Goserelin; Humans; Iodine Radioisotopes; Leuprolide; Male; Middle Aged; Neoplasm Staging; Palladium; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Retrospective Studies; Risk; Treatment Failure

2002
Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy.
    International journal of radiation oncology, biology, physics, 2009, Sep-01, Volume: 75, Issue:1

    Topics: Analysis of Variance; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Biopsy; Brachytherapy; Flutamide; Follow-Up Studies; Goserelin; Humans; Iodine Radioisotopes; Leuprolide; Male; Nitriles; Palladium; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Relative Biological Effectiveness; Tosyl Compounds; Treatment Failure

2009